ALCL |
anaplastic large-cell lymphoma |
BAG-1 |
BCL-2 associated athanogene |
Bcl-3 |
B-cell lymphoma 3 |
C/EBP |
CCAAT enhancer-binding protein |
EBV |
Epstein–Barr virus |
EGFR |
epidermal growth factor receptor |
EMSA |
electrophoresis mobility shift assay |
ERK |
extracellular regulated kinase |
HCC |
hepatocellular carcinoma |
HDAC1 |
histone deacetylase 1 |
HPV16 |
human papilloma virus 16 |
IFN |
interferon |
IKK |
IκB kinase |
IL |
interleukin |
IκB |
inhibitor of kappa light polypeptide gene enhancer in B-cells |
JAK-STAT |
Janus kinase-Signal transducer and activator of transcription |
KPC1 |
Kip1 ubiquitination-promoting complex 1 |
LPS |
lipopolysaccharide |
MEK |
mitogen-activated protein kinase kinase |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
NF-κB |
nuclear factor of kappa light polypeptide gene enhancer in B-cells |
NSCLC |
non-small-cell lung carcinoma |
PD-L1 |
programmed death-ligand 1 |
PTEN |
phosphatase and tensin homolog |
SCCHN |
squamous cell carcinoma of the head and neck |
STAT |
signal transducer and activator of transcription |
TAD |
transcriptional activation domain |
TIM-3 |
T-cell immunoglobulin and mucin-domain containing-3 |
TNFα |
tumour necrosis factor α |
TPL-2 |
tumour progression locus 2 |